Long-Term Oncologic Outcome Following Duodenum-Preserving Pancreatic Head Resection for Benign Tumors, Cystic Neoplasms, and Neuroendocrine Tumors: Systematic Review and Meta-analysis

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2024 Apr 5

PMID 38578553

Authors

Hans G Beger

Benjamin Mayer

Bertram Poch

Affiliations

Soon will be listed here.

Abstract

Background: Pancreatoduodenectomy (PD) has a considerable surgical risk for complications and late metabolic morbidity. Parenchyma-sparing resection of benign tumors has the potential to cure patients associated with reduced procedure-related short- and long-term complications.

Materials And Methods: Pubmed, Embase, and Cochrane libraries were searched for studies reporting surgery-related complications following PD and duodenum-preserving total (DPPHRt) or partial (DPPHRp) pancreatic head resection for benign tumors. A total of 38 cohort studies that included data from 1262 patients were analyzed. In total, 729 patients underwent DPPHR and 533 PD.

Results: Concordance between preoperative diagnosis of benign tumors and final histopathology was 90.57% for DPPHR. Cystic and neuroendocrine neoplasms (PNETs) and periampullary tumors (PATs) were observed in 497, 89, and 31 patients, respectively. In total, 34 of 161 (21.1%) patients with intraepithelial papillar mucinous neoplasm exhibited severe dysplasia in the final histopathology. The meta-analysis, when comparing DPPHRt and PD, revealed in-hospital mortality of 1/362 (0.26%) and 8/547 (1.46%) patients, respectively [OR 0.48 (95% CI 0.15-1.58); p = 0.21], and frequency of reoperation of 3.26 % and 6.75%, respectively [OR 0.52 (95% CI 0.28-0.96); p = 0.04]. After a follow-up of 45.8 ± 26.6 months, 14/340 patients with intraductal papillary mucinous neoplasms/mucinous cystic neoplasms (IPMN/MCN, 4.11%) and 2/89 patients with PNET (2.24%) exhibited tumor recurrence. Local recurrence at the resection margin and reoccurrence of tumor growth in the remnant pancreas was comparable after DPPHR or PD [OR 0.94 (95% CI 0.178-5.34); p = 0.96].

Conclusions: DPPHR for benign, premalignant neoplasms provides a cure for patients with low risk of tumor recurrence and significantly fewer early surgery-related complications compared with PD. DPPHR has the potential to replace PD for benign, premalignant cystic and neuroendocrine neoplasms.

Citing Articles

Laparoscopic Duodenum and Spleen-Preserving Subtotal or Total Pancreatectomy: A Parenchyma-Sparing Strategy for Main Duct Intraductal Papillary Mucinous Neoplasms (with Video).

Li Z, Shi Y, Tang W, Chen C, Liu W, Zhuo Q Ann Surg Oncol. 2024; 31(13):8734-8740.

PMID: 39312053 PMC: 11549168. DOI: 10.1245/s10434-024-16244-2.

Preservation of Pancreatic Function Should Not Be Disregarded When Performing Pancreatectomies for Pancreatoblastoma in Children.

Dumitrascu T Pediatr Rep. 2024; 16(2):385-398.

PMID: 38804376 PMC: 11130799. DOI: 10.3390/pediatric16020033.

[Premalignant cystic neoplasms and neuroendocrine tumors of the pancreatic head-Is the Kausch-Whipple resection an adequate treatment?].

Beger H Chirurgie (Heidelb). 2024; 95(6):461-465.

PMID: 38568302 PMC: 11096214. DOI: 10.1007/s00104-024-02070-5.

Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity.

Beger H, Mayer B, Poch B J Gastrointest Surg. 2023; 27(11):2611-2627.

PMID: 37670106 PMC: 10661729. DOI: 10.1007/s11605-023-05789-4.

References

Kromrey M, Bulow R, Hubner J, Paperlein C, Lerch M, Ittermann T . Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2017; 67(1):138-145. DOI: 10.1136/gutjnl-2016-313127. View

Sahora K, Mino-Kenudson M, Brugge W, Thayer S, Ferrone C, Sahani D . Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013; 258(3):466-75. DOI: 10.1097/SLA.0b013e3182a18f48. View

Sahora K, Fernandez-Del Castillo C, Dong F, Marchegiani G, Thayer S, Ferrone C . Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery. 2014; 156(3):611-21. PMC: 5614499. DOI: 10.1016/j.surg.2014.04.023. View

Tanaka M, Fernandez-Del Castillo C, Adsay V, Chari S, Falconi M, Jang J . International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012; 12(3):183-97. DOI: 10.1016/j.pan.2012.04.004. View

Wang P, Wei J, Wu J, Xu W, Chen Q, Gao W . Diagnosis and treatment of solid-pseudopapillary tumors of the pancreas: A single institution experience with 97 cases. Pancreatology. 2018; 18(4):415-419. DOI: 10.1016/j.pan.2017.12.012. View

Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N . Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry. World J Surg. 2018; 43(1):175-182. DOI: 10.1007/s00268-018-4751-2. View

Newhook T, LaPar D, Lindberg J, Bauer T, Adams R, Zaydfudim V . Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015; 19(6):1072-7. DOI: 10.1007/s11605-015-2799-y. View

Mavroeidis V, Russell T, Clark J, Adebayo D, Bowles M, Briggs C . Pancreatoduodenectomy for suspected malignancy: nonmalignant histology confers increased risk of serious morbidity. Ann R Coll Surg Engl. 2022; 105(5):446-454. PMC: 10149251. DOI: 10.1308/rcsann.2022.0055. View

Nimptsch U, Krautz C, Weber G, Mansky T, Grutzmann R . Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated. Ann Surg. 2016; 264(6):1082-1090. DOI: 10.1097/SLA.0000000000001693. View

10.

Liu Z, Peneva I, Evison F, Sahdra S, Mirza D, Charnley R . Ninety day mortality following pancreatoduodenectomy in England: has the optimum centre volume been identified?. HPB (Oxford). 2018; 20(11):1012-1020. DOI: 10.1016/j.hpb.2018.04.008. View

11.

Reid-Lombardo K, Ramos-De la Medina A, Thomsen K, Harmsen W, Farnell M . Long-term anastomotic complications after pancreaticoduodenectomy for benign diseases. J Gastrointest Surg. 2007; 11(12):1704-11. DOI: 10.1007/s11605-007-0369-7. View

12.

Narayanan S, Martin A, Turrentine F, Bauer T, Adams R, Zaydfudim V . Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res. 2018; 231:304-308. PMC: 8246070. DOI: 10.1016/j.jss.2018.05.075. View

13.

Beger H, Mayer B, Vasilescu C, Poch B . Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis. Ann Surg. 2021; 275(1):54-66. DOI: 10.1097/SLA.0000000000004757. View

14.

Thomas A, Huang Y, Kwon W, Schrope B, Sugahara K, Chabot J . Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy. J Gastrointest Surg. 2022; 26(7):1425-1435. DOI: 10.1007/s11605-022-05302-3. View

15.

Talamini M, Moesinger R, Yeo C, Poulose B, Hruban R, Cameron J . Cystadenomas of the pancreas: is enucleation an adequate operation?. Ann Surg. 1998; 227(6):896-903. PMC: 1191400. DOI: 10.1097/00000658-199806000-00013. View

16.

Beger H, Siech M, Poch B, Mayer B, Schoenberg M . Limited surgery for benign tumours of the pancreas: a systematic review. World J Surg. 2015; 39(6):1557-66. DOI: 10.1007/s00268-015-2976-x. View

17.

Iacono C, Verlato G, Ruzzenente A, Campagnaro T, Bacchelli C, Valdegamberi A . Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 2013; 100(7):873-85. DOI: 10.1002/bjs.9136. View

18.

Fujii T, Kanda M, Kodera Y, Nagai S, Sahin T, Kanzaki A . Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head. Pancreas. 2011; 40(8):1258-63. DOI: 10.1097/MPA.0b013e318220b1c0. View

19.

Asano T, Nakamura T, Noji T, Okamura K, Tsuchikawa T, Ebihara Y . Outcomes of limited resection for patients with intraductal papillary mucinous neoplasm of the pancreas: A single-center experience. Pancreatology. 2020; 20(7):1399-1405. DOI: 10.1016/j.pan.2020.09.008. View

20.

Beger H, Mayer B, Poch B . Resection of the duodenum causes long-term endocrine and exocrine dysfunction after Whipple procedure for benign tumors - Results of a systematic review and meta-analysis. HPB (Oxford). 2020; 22(6):809-820. DOI: 10.1016/j.hpb.2019.12.016. View